Michael Dewain Kalos

Follow

Person

Brooklyn, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
Anti-CD137 antibodies
- Patent number 11,512,134
- Issue date Nov 29, 2022
- Eli Lilly and Company
- Christopher Carl Frye
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Checkpoint inhibitor bispecific antibodies
- Patent number 11,203,640
- Issue date Dec 21, 2021
- Eli Lilly and Company
- Michael Dewain Kalos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD137 antibodies
- Patent number 10,906,983
- Issue date Feb 2, 2021
- Eli Lilly and Company
- Christopher Carl Frye
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTI-CD137 ANTIBODIES
- Publication number 20230279134
- Publication date Sep 7, 2023
- Eli Lilly and Company
- Christopher Carl FRYE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD137 ANTIBODIES FOR COMBINATION WITH ANTI-PD-1 ANTIBODIES
- Publication number 20210054089
- Publication date Feb 25, 2021
- Eli Lilly and Company
- Michael Dewain KALOS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD137 ANTIBODIES
- Publication number 20200377607
- Publication date Dec 3, 2020
- Eli Lilly and Company
- Christopher Carl FRYE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD137 ANTIBODIES
- Publication number 20200157234
- Publication date May 21, 2020
- Eli Lilly and Company
- Christopher Carl FRYE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Checkpoint Inhibitor Bispecific Antibodies
- Publication number 20190010232
- Publication date Jan 10, 2019
- Eli Lilly and Company
- Michael Dewain Kalos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE